Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoketang plus valsartan for diabetic nephropathy
ChiCTR2000036692Phase 2Not yet recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of valsartan and Xiaoketang in diabetic glomerulosclerosis (2 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoints: Blood sugar, Serum creatinine and 6 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
valsartanXiaoketang
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2000036692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036692.